Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

IPO/Stock Watch

Market trends, bell-weather stocks, filings and IPOs...

ArriVent Completes $175 Million NASDAQ IPO to Bring Assets from China to the US

Xtalpi, a Quantum Physics-AI Drug Discovery Company, Files for Hong Kong IPO

WuXi XDC Raises $520 Million in IPO; Climbs 39% in First Trading Session

WuXi XDC, an ADC/Bioconjugates CRDMO, Stages $500 Million IPO

QYuns, an Autoimmune/Allergic Disease Biotech, Files for Hong Kong IPO

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital